Pharmaceuticals, Biotechnology and Life Sciences
Novarits is expanding its ophthalmology pipeline as it secured the ownership of a US-based private company focused on treating long-sightedness.
Silence Therapeutics and Quark Pharmaceuticals have settled in the arbitration regarding a milestone payment, as Silence is to receive a…
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to orphan drug Rubraca (rucaparib) to treat women with…
Novartis and Conatus Pharmaceuticals have signed a multipurpose deal which will help the two drug makers to make liver-disease treatment,…
The U.S. Food and Drug Administration (FDA) has found that the mental-health side effect risk of Pfizer’s and GSK’s quitting…
Adocia and Eli Lilly have completed an insulin pump study under the Adocia-Lilly partnership evaluating BioChaperone Lispro, an ultra-rapid formulation…
The American Diabetes Association (ADA) has included new recommendation about the use of Jardiance tablets for type 2 diabetes patients…
Janssen Biotech is looking to expand the usage of its prescription drug Stelara, as it has asked the U.S. Food…
Eli Lilly and Incyte Corporation have gotten positive opinion from European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
Mylan is launching its generic for EpiPen adrenaline injection at a wholesale acquisition cost (WAC) of $300 per epinephrine injection. As…